We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topics
- Shortages and supply disruptions (23)
- Safety monitoring and information (11)
- Manufacturing (7)
- Compliance and enforcement (6)
- Labelling and packaging (4)
- Import and export (3)
- Scheduling (national classification system) (3)
- Committees and advisory bodies (2)
- Legislation (2)
- Advertising (1)
- Clinical trials (1)
- Fees and payments (1)
- Medicinal cannabis hub (1)
- Weight loss products (1)
Collection content
116 result(s) found, displaying 111 to 116
-
Medicine shortage alertsConcerta modified-release tablets will remain in shortage at various times until the end of 2026
-
Medicine shortage alertsClinical guidance for prescribers during the shortages is available.
-
Medicine shortage alertsWe have approved overseas-registered substitutes for Pegasys 135 micrograms/0.5 mL and 180 micrograms/0.5 mL pre-filled syringes.
-
Medicine shortage alertsRitalin and Artige immediate-release tablets are now also in shortage, and a shortage of Ritalin LA capsules is anticipated.
-
Corporate reportsThese guidelines apply to company-sponsored post-marketing surveillance studies of drug safety and toxicity
-
Corporate reportsTGA approach to disclosure of commercially confidential information (CCI)